Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.35 (-0.70) | AIM:£3.24 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 14 Oct 2023

HMPL-653, a highly potent and selective CSF-1R inhibitor, targets both tumor cells and tumor microenvironment